Rheumatology (Oct 2023)

Temporomandibular joint disorders in seronegative spondyloarthritis: what a rheumatologist needs to know?

  • Vasiliki Syrmou,
  • Maria G. Grammatikopoulou,
  • Dimitrios P. Bogdanos,
  • Konstantinos T. Mitsimponas

DOI
https://doi.org/10.5114/reum/173078
Journal volume & issue
Vol. 61, no. 5
pp. 375 – 388

Abstract

Read online

Temporomandibular joint (TMJ) can be affected in the context of spondyloarthritis (SpA) with detrimental impact on individuals’ quality of life. Intraarticular inflammation, synovitis, enthesitis, disc displacement and cervical vertebrae malalignment are some of the pathophysiological phenomena involved. Temporomandibular joint disorders (TMD) incidence appears to be higher in patients with ankylosing spondylitis and psoriatic arthritis, especially when clinical evaluation includes not only imaging but relevant history, TMJ examination and diagnostic criteria for TMD. The Visual Analogue Scale (VAS) pain score and Health Assessment Questionnaire Disability Index (HAQ) quality of life score could be useful tools. Panoramic radiographs and ultrasound can be used for screening but in symptomatic patients magnetic resonance imaging (MRI) is preferable. Conservative management and early pharmacological treatment can prevent permanent joint impairment. For refractory cases, early referral to Legislation for Oral and Maxillofacial Surgery (OMFS) specialists is indicated. The aim of this narrative review is to address the involvement of TMJ in SpA and to encourage clinicians to incorporate TMJ assessment in their physical examination and basic screening.

Keywords